Pharmaceutical capsules in controlled manufacturing environment

Enabling validated, audit-ready remote access across pharma production sites

Index

About

A global biopharmaceutical company initiated a project to modernize and standardize secure remote access across its production environments. The goal was to establish a validated, scalable framework that could be rolled out across multiple sites globally – while meeting strict internal cybersecurity, legal, and compliance requirements.

In our customer’s
own words

“We needed secure remote access that could meet our validation and cybersecurity requirements without slowing down operations – and scale across sites from day one.”

The challenge

Operating in a highly regulated pharmaceutical sector, a global manufacturer needed to enable remote access to production environments while meeting strict internal requirements for validation, cybersecurity, and auditability.

However, their existing setup created operational and compliance challenges:

    • Remote access was not consistently controlled across production sites
    • System integrations between sites could not be tested before deployment
    • Issues were often identified late – during commissioning or after installation
    • Internal requirements for cybersecurity, validation, and legal approval made it difficult to introduce new solutions

The organization needed an approach that could support both GxP expectations and operational efficiency, without adding complexity or risk.

The solution

Capsules in blister packaging for pharmaceutical distribution

Following a comprehensive evaluation and alignment process, the company selected Secomea to establish a secure, controlled, and scalable remote access model aligned with pharmaceutical requirements.

Secomea enabled:

    • Outbound-only connectivity (which eliminated the need to open inbound firewall ports)
    • Role-based access control and multi-factor authentication
    • Full session logging and traceability to support validation and audits
    • Clear ownership and governance of user access
    • Remote access aligned with internal validation processes
    • No processing or storage of production data within the platform
    • Validated integrations early in the lifecycle
    • Reduced need for on-site troubleshooting and rework

The result

With Secomea, the organization established a standardized model for multi-site deployment that supports both compliance and operational efficiency

    • providing a validated, audit-ready approach that can be replicated across sites,
    • eliminating the need to redesign or re-evaluate remote access for each location,
    • enabling a consistent security and operational model globally.

Secure remote access is now aligned with internal cybersecurity and GxP requirements, and there is full visibility and control over who accesses production systems and how.

In other words, it is now a controlled, governed, and scalable capability – rather than a fragmented or site-specific workaround.

You can download this case study as a PDF here.

Learn more about how Secomea supports production environments in pharmaceutical manufacturing. 

Don't miss these

OT on Tour: Join us in Copenhagen on November 9!